NCT00688402View on ClinicalTrials.gov

Study to Compare Different Formulations of AZD3355

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

AZD3355

Single dose

Trial Locations (1)

Unknown

Research Site, Varvsgatan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY